ArticleCancers2020

Efficacy of Crizotinib, Ceritinib, and Alectinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Meta-Analysis of Clinical Trials.

Tung Hoang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.